Five Year Survival Study Evaluating the Genesis Dental Implant System

Inclusion Criteria: * Subject must be between 18 and 85 years old, inclusive, and have passed growth maximum at the time of implant placement * Subject must be willing to sign the informed consent document and adhere to study procedures. * Subject must have one or more natural teeth missing or about to be extracted. * Subject must fulfill all the accepted medical and dental requirements for treatment with dental implants. * Subject must desire treatment with dental implants. Exclusion Criteria: * Subject refuses to sign the informed consent document. * Subject's treatment success by both clinical and esthetic measures may be compromised by the restricted range of product available for the study. * The treatment plan to use the range of products available is not in the best interests of the subject. Please see Section 1.2.1 for restrictions on product availability. * The implant site(s) had a previously failed implant. * Subject cannot be treated within the restrictions of the treatment plan laid out in Section 5. In addition, please see Section 1.2.1 for restrictions on product availability. * Subject with alveolar ridge dimensions that are not sufficient to accommodate and sustain proper implant placement. * Subject is not communicable in an understandable language. * Current Alcohol or Drug Abuse (within previous 12 months) as noted in the subject's chart. * Women who are pregnant at time of enrollment in to the study. * Subject with out of control metabolic disease. * Subject who have been on chemotherapy or long term cortisone use (at any time). * Subject with known allergy to titanium. * Subject with diabetes. * Subject with a history of autoimmune disease (e.g. documented multiple allergies, systemic lupus erythematosus, dermatomyositis, etc.) or immunosuppressive disease (e.g. human immunodeficiency virus or acquired immunodeficiency syndrome). * Subject with epilepsy. * Subjects with uncontrolled or severe cases of hyperthyroidism, malignancies, renal disease, liver problems, hypertension, leukemia, severe vascular heart disease, hepatitis, collagen and bone diseases, or other serious illnesses. * Subject currently taking bisphosphonate or calcium channel blockers. * There is reasonable doubt that the subject will comply with the recall schedule. * There is reasonable doubt that the subject will comply with the clinicians' instructions.